003 – Autonomy of Children With Type I Diabetes on Insulin Pump Therapy

2014 ◽  
Vol 29 (3) ◽  
pp. 292
Author(s):  
Woerner Stephanie ◽  
Linda A. DiMeglio ◽  
Hanna Kathleen ◽  
Rahhal Samar
2020 ◽  
Vol 36 (6) ◽  
pp. 57-63
Author(s):  
O. M. Khudorozhkova ◽  
E. N. Smirnova

Aim. To assess the dependence of carbohydrate metabolism state in children and adolescents with type I diabetes mellitus (DM) in Perm Krai on patients age, disease duration, way of insulin administration (regimen of multiple insulin injections or insulin pump therapy), complications available. Materials and methods. The study enclosed 451 children and adolescents, living in Perm Krai, who were hospitalized for type 1 DM to Endocrine Unit of Regional Childrens Clinical Hospital during 2016-2017. Glycated hemoglobin level (HbA1c), daily insulin requirement, availability and character of complications were assessed in these patients. Conclusions. The state of decompensation more often is connected with the disease duration for more than 5 years and adolescent age. There was detected a feedback between the physical development level and the duration of disease and number of chronic complications. The period of development of type 1 DM chronic complications depends on patients age, sex and compensation of disease. The degree of compensation of the disease is higher when using insulin pump therapy or regimen of multiple injections of ultrashort analogs of insulin in combination with basal analogs.


1984 ◽  
Vol 20 (6) ◽  
pp. 1498
Author(s):  
C. Whiteside ◽  
S. Zuniga-Guajardo ◽  
B. Zinman ◽  
M. Silverman

2021 ◽  
Vol 12 ◽  
Author(s):  
Ling Hou ◽  
Xiuzhen Li ◽  
Li Liu ◽  
Hanyang Wei ◽  
Feng Xiong ◽  
...  

PurposeTo investigate the features and treatment status of children with type 1 diabetes mellitus (T1DM) in China.MethodsWe recruited patients <14 years of age with T1DM from 33 medical centers in 25 major cities of China between January 2012 and March 2015. All patients completed a questionnaire that was conducted by their pediatric endocrinologists at all centers.ResultsA total of 1,603 children (755 males and 848 females) with T1DM participated in this survey. Of these, 834 (52.03%) of the patients exhibited diabetic ketoacidosis (DKA) at onset, while 769 patients (47.97%) did not exhibit DKA (non-DKA) at onset. There was a higher proportion of females (55.71%) in the cohort of patients exhibiting DKA at onset than in the non-DKA cohort (49.33%). The mean age of patients exhibiting DKA at presentation was 7.12 ± 0.14 years; this was significantly younger than that in non-DKA group (7.79 ± 0.15 years; P < 0.005). The frequency of DKA in 3 years old, 3-7 years old, and 7 years old or more was 77.21%, 26.17%, and 37.62%, respectively. Upon initial diagnosis, 29.4%, 15.2% and 11.8% of patients showed positivity for glutamic acid decarboxylase antibody (GADA), Insulin autoantibodies (IAA), or islet cell antibody (ICA), respectively. During six months follow-up, 244 patients (15.21%) reported receiving insulin pump therapy, and more than 60% of patients monitored their blood glucose levels less than 35 times per week. Although the majority of patients had no problems with obtaining insulin, 4.74% of the children surveyed were not able to receive insulin due to financial reasons, a shortage of insulin preparations, or the failure of the parents or guardians to acquire the appropriate medicine.ConclusionDKA is more common in very young children. Treatment and follow-up of T1DM in China still face very serious challenges.


The Lancet ◽  
1984 ◽  
Vol 323 (8374) ◽  
pp. 411-413 ◽  
Author(s):  
Michael Brownlee ◽  
Anthony Cerami ◽  
JennyJ. Li ◽  
Helen Vlassara ◽  
TerryR. Martin ◽  
...  

2006 ◽  
Vol 74 (3) ◽  
pp. 217-221 ◽  
Author(s):  
Zeina M. Nabhan ◽  
Laura Rardin ◽  
Jill Meier ◽  
Erica A. Eugster ◽  
Linda A. DiMeglio

2016 ◽  
Author(s):  
Sladana Pejaković ◽  
Dragan Tešić ◽  
Edita Stokić ◽  
Andrijana Milankov ◽  
Jovana Prodanović ◽  
...  

2022 ◽  
Vol 67 (4) ◽  
pp. 195-202
Author(s):  
Lv Jianjun ◽  
Liu Xiaona ◽  
Li Hong

Diabetes is associated with an increase in other chronic diseases and an increase in mortality. The individual differences influence the treatment of this disease in pharmacokinetics and clinical responses. One of the important factors related to individual differences includes genetic factors in transmission, metabolism, and drug function. On the other hand, this disease has a significant impact on the patients’ quality of life and their family. Therefore, this study aimed to investigate the role of single nucleotide polymorphism (rs2110385) of the visfatin gene on insulin required to maintain glucose homeostasis and to evaluate the effect of insulin pump therapy on the quality of life in type 1 diabetic patients. In this regard, this study was performed on 47 patients with type 1 diabetes. The short form of the Diabetes Quality of Life Questionnaire (DQOL) was used to record information. Laboratory tests also included FBS, HbA1C, G2h, serum levels of visfatin, insulin, and adiponectin. Insulin resistance (HOMA) and insulin sensitivity (QUICKI) indices were calculated. The polymorphism of the studied genotype was performed by the PCR-RFLP method. The results showed that the scores of both dimensions of quality of life, including patient care behaviors and satisfaction with the disease control after the intervention increased significantly (P <0.001). There was a significant and direct relationship between the patient's age and the duration of the disease with the score of increasing patients' quality of life. No significant differences were found between HbA1C, G2h, FBS levels, fasting insulin concentration, HOMA, and QUICKI indices. The insulin dose used to maintain glucose homeostasis at the same levels was significantly lower in the GG genotype than in other genotypes. In general, the present study results showed that insulin pump therapy and its dimensions could improve the life quality of patients with type 1 diabetes. Also, genetic evaluation of individuals helps to provide the correct and accurate dose of insulin with the help of the insulin pump for these patients to increase their quality of life as much as possible.


Sign in / Sign up

Export Citation Format

Share Document